Anterior tibialis cmap amplitude correlations with impairment in CMT1A

Muscle and Nerve

Volumn 47, Issue 4, 2013, Pages 493-496

  Komyathy, Kelsey ^a   Neal, Stephanie ^a   Feely, Shawna ^b   Miller, Lindsey J ^a   Lewis, Richard A ^a   Trigge, George ^a   Siskind, Carly E ^c   Shy, Michael E ^b   Ramchandren, Sindhu ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Charcot Marie Tooth Disease (CMT); Charcot Marie Tooth Neuropathy Score (CMTNS); Nerve Conduction Studies (NCS); Neuropathy; Outcome measure

Indexed keywords

ADULT; ARTICLE; CHARCOT MARIE TOOTH DISEASE 1A; DISEASE ASSOCIATION; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MUSCLE ACTION POTENTIAL; MUSCLE DISEASE; MUSCLE WEAKNESS; PRIORITY JOURNAL; SCORING SYSTEM; TIBIALIS ANTERIOR MUSCLE;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHARCOT-MARIE-TOOTH DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIAGNOSTIC TECHNIQUES, NEUROLOGICAL; DISEASE PROGRESSION; FEMALE; HUMANS; LEG; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEURAL CONDUCTION; PERONEAL NERVE; RETROSPECTIVE STUDIES;

EID: 84875618128     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23614     Document Type: Article

References (17)

1. Skre H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin Genet 1974;6:98-118.
2. Thomas PK, Marques W Jr, Davis MB, Sweeney MG, King RH, Bradley JL, et al. The phenotypic manifestations of chromosome 17p11.2 duplication. Brain 1997;120:465-478.
3. Lupski JR, de Oca-Luna RM, Slaugenhaupt S, Pentao L, Guzzeta V, Trask BJ, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66:219-232.
4. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991;1:93-97.
5. Niemann A, Berger P, Suter U. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 2006;8:217-242.
6. Krajewski KM, Lewis RA, Fuerst DR, Turansky C, Hinderer SR, Garbern J, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000;123:1516-1527.
7. Shy ME, Blake J, Krajewski K, Fuerst DR, Laura M, Hahn AF, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209-1214.
8. Murphy SM, Herrmann DN, McDermott MP, Scherer SS, Shy ME, Reilly MM, et al. Reliability of the CMT neuropathy score (second version) in Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2011;16:191-198.
9. Shy ME, Chen L, Swan ER, Taube R, Krajewski KM, Herrmann D, et al. Neuropathy progression in Charcot-Marie-Tooth disease type 1A. Neurology 2008;70:378-383.
10. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, et al. CMT-TRIAAL; CMT-TRAUK groups. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011;10:320-328.
11. Gallardo E, Garcia A, Combarros O, Berciano J. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 2006;129(Pt 2):426-437.
12. Chung KW, Suh BC, Shy ME, Cho SY, Yoo JH, Park SW, et al. Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A. Neuromuscul Disord 2008;18:610-618.
13. Preston DC, Shapiro BE. Electromyography and neuromuscular disorders. Clinical-electrophysiologic correlations, 2nd ed. Philadelphia: Elsevier/Butterworth Heinemann; 2005. p148-149.
14. Reilly MM, Shy ME. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009;80:1304-1314.
15. Shy ME, Siskind C, Swan ER, Krajewski KM, Doherty T, Fuerst DR, et al. CMT1X phenotypes represent loss of GJB1 gene function. Neurology 2007;68:849-855.
16. Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy types I and II. Brain 1980;103:259-280.
17. Cornblath DR, Chaudhry V, Carter K, Lee D, Seysedadr M, Miernicki M, et al. Total neuropathy score: validation and reliability study. Neurology 1999;53:1660-1664.